Bespoke Extracts in change-of-control deal; CEO Pollack sells 50M shares for $40K

Bespoke Extracts, Inc.

Danil Pollack sells 50M common shares and 1 Series C share (51% voting) to Infinity Management for $40,000 cash.
Michael Feinsod to become CEO and Chairman; Hunter Garth appointed director and chief strategy officer.
Convertible debenture (~$400K) terminated; company to pay 40% of CBD inventory profit monthly plus $75K final payment.
Buyer contributes $4,792 to pay creditors; closing subject to Schedule 14F-1 filing.
Pollack to resign as president, CEO, CFO, and board member at closing.

item 1.01 item 1.02 item 5.01 item 5.02 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.